Sonendo Inc
NYSE:SONX
Sonendo Inc
Total Equity
Sonendo Inc
Total Equity Peer Comparison
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sonendo Inc
NYSE:SONX
|
Total Equity
$28.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Equity
$19.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
12%
|
|
Stryker Corp
NYSE:SYK
|
Total Equity
$19.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
Abbott Laboratories
NYSE:ABT
|
Total Equity
$38.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Equity
$14B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
14%
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Total Equity
$751.8m
|
CAGR 3-Years
54%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
See Also
What is Sonendo Inc's Total Equity?
Total Equity
28.4m
USD
Based on the financial report for Dec 31, 2023, Sonendo Inc's Total Equity amounts to 28.4m USD.
What is Sonendo Inc's Total Equity growth rate?
Total Equity CAGR 3Y
1%
Over the last year, the Total Equity growth was -65%. The average annual Total Equity growth rates for Sonendo Inc have been 1% over the past three years .